2016
article
OpenAlex
Keith Abe, Michael Wright, Derek Sim, Magdalena Alonso‐Galicia et autres
Abstract Introduction: Sickle cell disease (SCD) is a debilitating genetic disorder of the red blood cells, leading to acute vaso-occlusive (VOC) events and chronic disease in multiple organs. In the liver, VOC events in the hepatic sinusoids can lead to fatal sickle …
us
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Yuping Zhu, Reynalda K. de Jesus, Haifeng Tang, Shawn P. Walsh et autres
us
(code pays fourni par la source)
2016
article
OpenAlex
Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai et autres
us
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Haifeng Tang, Yuping Zhu, Nardos Teumelsan, Shawn P. Walsh et autres
ROMK, the renal outer medullary potassium channel, is involved in potassium recycling at the thick ascending loop of Henle and potassium secretion at the cortical collecting duct in the kidney nephron. Because of this dual site of action, selective inhibitors of ROMK …
us
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Shawn P. Walsh, Aurash Shahripour, Haifeng Tang, Reynalda K. de Jesus et autres
us
(code pays fourni par la source)
2015
article
OpenAlex
Michael Wright, Derek Sim, Magdalena Alonso‐Galicia, Katalin Kauser et autres
Abstract Introduction: Sickle cell disease (SCD) is a debilitating genetic disorder, and the resultant "sickling" deformity of red blood cells leads to acute vasoocclusive (VOC) events and chronic disease in multiple organs. Sickle cell hepatopathy, arising from VOC events in the hepatic …
us
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Shawn P. Walsh, Aurash Shahripour, Haifeng Tang, Nardos Teumelsan et autres
A new subseries of ROMK inhibitors exemplified by 28 has been developed from the initial screening hit 1. The excellent selectivity for ROMK inhibition over related ion channels and pharmacokinetic properties across preclinical species support further preclinical evaluation of 28 as a …
us
(code pays fourni par la source)
2014
conference-abstract
OpenAlex
Javier Milara, Javier Lluch, Adela Serrano, Jose Freire et autres
Introduction: Roflumilast N-oxide (RNO) has anti-inflammatory activities and reverses corticosteroid resistance in COPD neutrophils. This study further explored the anti-inflammatory effects of RNO, dexamethasone (DEX) and formoterol and their combinations in human neutrophils from healthy non-smokers and COPD patients. Methods: Neutrophils were …
es, in
(code pays fourni par la source)
2013
article
OpenAlex
María L. García, Birgit T. Priest, Magdalena Alonso‐Galicia, Xiaoyan Zhou et autres
us
(code pays fourni par la source)
Accès ouvert
2013
article
OpenAlex
Haifeng Tang, Reynald K. de Jesus, Shawn P. Walsh, Yuping Zhu et autres
us
(code pays fourni par la source)
2013
conference-abstract
OpenAlex
Javier Milara, Javier Lluch, Patricia Almudéver, Teresa Peiró et autres
Objective Bacterial and viral infections in COPD contribute to inflammation and exacerbations, and toll-like receptors (TLR) modulate the innate immune response to these infectious agents. This study explored the anti-inflammatory effects of dexamethasone (DEX) and roflumilast N-oxide (RNO) following TLR stimulation and …
es
(code pays fourni par la source)
2013
article
OpenAlex
Jean Tyrrell, Maohua Qian, Magdalena Alonso‐Galicia, Jose Freire et autres